Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hernan Roca

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Bonekey Reports|July 2, 2015
Inflammation and skeletal metastasisHernan Roca, Laurie K McCauley
Nucleic Acids Research|February 12, 2008
Analysis of transcription factor interactions in osteoblasts using competitive chromatin immunoprecipitationHernan Roca, Renny T Franceschi
Oncoscience|July 24, 2018
Efferocytosis and prostate cancer skeletal metastasis: implications for interventionHernan Roca, Laurie K McCauley
Clinical Spine Surgery|November 25, 2024
How to Estimate the Minimal Clinically Important Difference: An OverviewHernan Roca, Gretchen Maughan, Brian Karamian
The Journal of Biological Chemistry|July 10, 2008
CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulationHernan Roca, Zachary Varsos, Kenneth J Pienta
Neoplasia (New York, N.Y.)|December 19, 2009
CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cellsHernan Roca, Zachary S Varsos, Kenneth J Pienta
Journal of Spine Surgery (Hong Kong)|April 11, 2023
Opioid prescriptions in a veteran population undergoing lumbar spine surgery: what are the current knowledge gaps?Mark J Lambrechts, Hernan Roca, Brian A Karamian
Anticancer Research|August 8, 2009
Possible mechanism of CCL2-induced Akt activation in prostate cancer cellsKosuke Mizutani, Hernan Roca, Zachary Varsos, et al.
The Journal of the American Academy of Orthopaedic Surgeons|July 7, 2023
Patient-Reported Outcome Measurement and Minimal Clinically Important Difference for Hand SurgeonsBrittany N Garcia, Andrew Tyser, Hernan Roca, et al.
Bone Research|November 12, 2015
Juxtacrine interaction of macrophages and bone marrow stromal cells induce interleukin-6 signals and promote cell migrationJia Chang, Amy J Koh, Hernan Roca, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Bonekey Reports|July 2, 2015
Inflammation and skeletal metastasisHernan Roca, Laurie K McCauley
Nucleic Acids Research|February 12, 2008
Analysis of transcription factor interactions in osteoblasts using competitive chromatin immunoprecipitationHernan Roca, Renny T Franceschi
Oncoscience|July 24, 2018
Efferocytosis and prostate cancer skeletal metastasis: implications for interventionHernan Roca, Laurie K McCauley
Clinical Spine Surgery|November 25, 2024
How to Estimate the Minimal Clinically Important Difference: An OverviewHernan Roca, Gretchen Maughan, Brian Karamian
The Journal of Biological Chemistry|July 10, 2008
CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulationHernan Roca, Zachary Varsos, Kenneth J Pienta
Neoplasia (New York, N.Y.)|December 19, 2009
CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cellsHernan Roca, Zachary S Varsos, Kenneth J Pienta
Journal of Spine Surgery (Hong Kong)|April 11, 2023
Opioid prescriptions in a veteran population undergoing lumbar spine surgery: what are the current knowledge gaps?Mark J Lambrechts, Hernan Roca, Brian A Karamian
Anticancer Research|August 8, 2009
Possible mechanism of CCL2-induced Akt activation in prostate cancer cellsKosuke Mizutani, Hernan Roca, Zachary Varsos, et al.
The Journal of the American Academy of Orthopaedic Surgeons|July 7, 2023
Patient-Reported Outcome Measurement and Minimal Clinically Important Difference for Hand SurgeonsBrittany N Garcia, Andrew Tyser, Hernan Roca, et al.
Bone Research|November 12, 2015
Juxtacrine interaction of macrophages and bone marrow stromal cells induce interleukin-6 signals and promote cell migrationJia Chang, Amy J Koh, Hernan Roca, et al.
Pageof 5